Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 128 (1) , 152-164
- https://doi.org/10.1016/0008-8749(90)90014-i
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factorCellular Immunology, 1986
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.The Journal of Experimental Medicine, 1984
- Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains.The Journal of Experimental Medicine, 1984
- IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTSInternational Journal of Immunogenetics, 1983
- Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunityNature, 1983
- Lack of Expression of HLA Antigens on Choriocarcinoma Cell LinesTissue Antigens, 1980
- ABSENCE OF SEROLOGICALLY DETECTABLE H-2 ON PRIMITIVE TERATOCARCINOMA CELLS IN CULTURETransplantation, 1974